The latest news updates from the 2024 Symposium
Lisa Carey, MD, ScM, FASCO, will moderate Thursday afternoon discussions on axillary management of patients with breast cancer, treating small triple-negative breast cancer, and more.
Justin Balko, PharmD, PhD, will moderate a Thursday afternoon exploration of senescence in breast cancer and its role in immune microenvironment and therapeutic response.
Mikael Eriksson, PhD, and Kelly-Anne Phillips, MBBS, MD, FRACP, discuss their Thursday morning poster presentations.
Barbara Pistilli, MD, discusses a Thursday morning poster presentation analyzing the CAPItello-292 Phase 1b trial.
Amy Tiersten, MD, and Akihiko Shimomura, MD, PhD, discuss their Thursday poster presentations.
On Tuesday, December 5, panelists discussed how cancer outcomes can be adversely affected by environmental, social, cultural, psychological, clinical, biological, genetic, and behavioral factors.
SABCS® Co-Director Carlos Arteaga, MD, shares a few highlights from Wednesday’s schedule to help you plan your day, including cutting-edge oral and poster presentations, interactive educational sessions, and more.
Don’t miss Wednesday’s General Session abstract presentations and Poster Spotlight Session presentations, featuring research that has the potential to shape the future of breast cancer care.
Sherene Loi, MD, PhD, will moderate a Wednesday afternoon State-of-the-Art Session on purpose, resistance, and toxicity of immunotherapeutic approaches in breast cancer.
Icro Meattini, MD, discusses a Wednesday afternoon presentation on patient-friendly radiation courses with whole breast and partial breast irradiation.